A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the ...

The earlier Parkinson's disease is spotted, the better – for patients, their loved ones, and scientists working toward ...

Subthalamic nucleus stimulation is an effective treatment for motor complications and dyskinesia in Parkinson's disease, but is less effective on axial signs. Alternative treatments for axial ...

Most treatments for Parkinson's disease (PD) only slow disease progression. Early intervention for the neurological disease ...

This new type of brain imaging analysis is not only for studying Parkinson’s disease; any medications that affect brain signaling can be studied using the method developed by Wiesman and colleagues.